Resume
Download PDFProfessional Timeline
Experience
Head of Regulatory Affairs
2025 — PresentValar Labs
- Lead regulatory strategy for an AI-powered diagnostics platform
- Built the company's first regulatory function and quality processes
- Own FDA strategy across SaMD classification and De Novo planning
Senior Regulatory Affairs Lead
2021 — 2025Artera
- Led a significant regulatory authorization for a novel AI diagnostic
- Managed FDA interactions and submission strategy end-to-end
- Partnered with engineering and clinical teams on AI/ML documentation
Regulatory Affairs Specialist
2017 — 2021Prior healthcare organization
- Supported regulatory submissions across diagnostics and oncology
- Developed early expertise in software as a medical device (SaMD)
Education
Doctor of Pharmacy (PharmD) · University program
Speaking Engagements
DIA Regulatory Affairs Conference — Panel
HealthTech Founders Summit — Talk
RAPS Convergence — Panel
Publications
What 'Predetermined Change Control' Actually Means for Your AI Model
De Novo Is Not a Fallback. Treat It Like a Strategy.
Building a Regulatory Function Before You Think You Need One